Children's experiences of cystic fibrosis: a systematic review of qualitative studies

Nathan Jamieson1, Dominic Fitzgerald2, Davinder Singh-Grewal2

  • 1Kids Research Institute.

Pediatrics
|May 21, 2014
PubMed

Insights

Children and adolescents with cystic fibrosis (CF) experience vulnerability and loss of independence. Patient-centered care is crucial for improving their quality of life and treatment outcomes.

Area of Science:

  • Pediatric Health
  • Genetic Disorders
  • Psychosocial Outcomes

Background:

  • Cystic fibrosis (CF) is a prevalent, life-shortening genetic disorder.
  • CF significantly impacts psychosocial well-being and quality of life in young patients.

Purpose of the Study:

  • To explore the lived experiences and perspectives of children and adolescents with CF.
  • To inform care strategies by focusing on patient-identified priorities.

Main Methods:

  • Systematic literature search across major health databases (MEDLINE, Embase, PsycINFO, CINAHL) up to April 2013.
  • Thematic synthesis methodology applied to analyze findings from 43 included articles.

Main Results:

  • Six key themes emerged: resilience, lifestyle restrictions, treatment resentment, temporal limitations, emotional vulnerability, and transplant considerations.
  • Participants reported challenges including limited independence, social isolation, treatment burden, and emotional strain.
  • Experiences varied across age groups (4-21 years) and countries, highlighting diverse challenges.

Conclusions:

  • Children and adolescents with CF often feel vulnerable, disempowered, and isolated.
  • Multidisciplinary, patient-centered care models are vital.
  • Promoting shared decision-making, self-efficacy, and support for educational/social needs enhances outcomes.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...